SHANGHAI GROWTH (00770) has a net asset value per share of $0.11 at the end of 2024.

date
14/01/2025
avatar
GMT Eight
SHANGHAI GROWTH (00770) announced that as of December 31, 2024, the unaudited net asset value per share of the company was $0.11.
pre
Chalkis Health Industry (000972.SZ) plans to raise funds for the acquisition of related matters, trading suspended from January 14th.
HUTCHMED (00013) announced that VIKORY has received regular approval from the China National Medical Products Administration for the treatment of locally advanced or metastatic MET exon 14 skipping non-small cell lung cancer.
next

RECOMMEND

recommend

Cui Dongshu: In December 2024, domestic sales of lithium batteries reached 75.4Wh, a year-on-year increase of 57%.

date
40 min ago
recommend

The US government has allocated $590 million to Moderna (MRNA.US) for the development of avian flu vaccines.

date
1 h ago
recommend

CICC: Both active and passive foreign investors are withdrawing from the Chinese market.

date
2 h ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com